Orforglipron
Orforglipron is a small-molecule oral GLP-1 receptor agonist studied for non-peptide incretin mimetic activity and weight management. Research examines oral bioavailability, GLP-1R conformational activation, and glycemic control without injectable delivery.
For in vitro and laboratory research only. Not for human or veterinary administration. Not evaluated by the FDA.
Variants & Pricing
ORF6
Oral6mg × 100 tabs
$130
ORF12
Oral12mg × 100 tabs
$210
To request this compound, join Discord and open a ticket with the product code and variant.
Order via Discord